noli.

Register

Anthony Youn, MD@tonyyounmdInstagram

Comment MENOHAIR for a FREE guide or comment PODCAST or SPOTIFY for the podcast link! Here is what works for

… more

what it claims

The loss of hair density during menopause is caused by specific deficiencies, suggesting that external intake (supplementation) is necessary to restore hair follicle function.

mixed

Menopause does indeed lead to major hair changes, primarily linked to the drop in estrogen, which normally protects the hair life cycle.

noli's read

Menopause does indeed lead to major hair changes, primarily linked to the drop in estrogen, which normally protects the hair life cycle. It is scientifically established that deficiencies in iron, vitamin D, zinc, or B vitamins can exacerbate hair thinning, as highlighted in a review published in 'Dermatology and Therapy' (observational evidence/literature review). However, asserting that external intake is a universal solution is an oversimplification. While supplementation helps in cases of proven deficiency, it has little effect on the dominant hormonal component (female pattern hair loss). The idea that a single element is 'missing' is exaggerated, as the process is multifactorial, involving genetics, oxidative stress, and hormones. Evidence for 'miracle' hair supplements often remains limited or based on studies funded by manufacturers. A comprehensive approach including blood work is more relevant than systematic supplementation.

the sources

  1. 1Mosconi L, Berti V, Dyke J, et al. 2021

Claimed by Anthony Youn, MD. Noli grades the claim, never the person.

Decoded by Noli · July 18, 2026 · the original post

What the graded evidence says

Evidence
C

Linked to, not proven to cause.

Effect
brain gray matter volume, connectivity, glucose metabolism and amyloid-beta across menopause stages — Multimodal imaging showed stage-specific declines in gray matter volume, connectivity and metabolism specific to endocrine (not chronological) aging, followed by partial post-menopausal recovery/stabilization; more amyloid-beta in peri/post-menopausal APOE-4 carriers vs matched men.
Measured on
midlife women across pre-, peri- and post-menopause (cross-sectional neuroimaging), vs age-matched men

What’s uncertain

This is cross-sectional imaging, so it captures differences across stages rather than proving what each woman will experience, and the changes appear largely transient. It explains symptoms and motivates healthy habits; it is not a prediction of decline.

Anthony Youn, MD in the Register77 claims graded · solidity 86/100See their record →

More from Anthony Youn, MD

Others on this

Noli has read similar claims

Other advice in the Register that leans on the same research.

Noli, a firefly holding its lantern, at rest

Seen something like this? Send it to Noli.

Paste any health post from TikTok, Instagram, YouTube or X — or the advice itself, if someone just told you. About ten seconds, no account needed.